Thymosin-α1 and famciclovir combination therapy activates T cell response in patients with chronic HBV infection in immune tolerant phase.

被引：0
|
作者：
Lau, GK
Nanji, A
Hou, JL
Fong, DY
Yuen, ST
Lai, ST
Leung, YK
Leung, SK
Shiu-Kum, L
机构：
[1] Queen Mary Hosp, Hong Kong, Peoples R China
[2] Nanfang Hosp, Guangzhou, Peoples R China
[3] Clin Trial Ctr, Hong Kong, Peoples R China
[4] Princess Margaret Hosp, Hong Kong, Peoples R China
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
610
引用
收藏
页码：324A / 324A
页数：1
相关论文
共 50 条
  • [31] Serum Lipoprotein Profiles and Response to Pegylated Interferon Plus Ribavirin Combination Therapy in Patients With Chronic HCV Genotype 1b Infection
    Aizawa, Yoshio
    Shimada, Noritomo
    Abe, Hiroshi
    Seki, Nobuyoshi
    Aida, Yuta
    Ishiguro, Haruya
    Ika, Makiko
    Kato, Keizo
    Tsubota, Akihito
    HEPATITIS MONTHLY, 2013, 13 (05)
  • [32] Anti-CD137 treatment during the priming phase of an antiviral immune response results in CD8 T cell anergy and chronic infection
    Maris, CH
    Foell, J
    McCausland, M
    Whitmire, J
    Ahmed, R
    Jacob, J
    Mittler, RS
    FASEB JOURNAL, 2003, 17 (07): : C212 - C212
  • [33] Hepatitis B core-related antigen serum levels may be a predictor of acute flare of chronic hepatitis B among pregnant women in the immune-tolerant phase of chronic HBV infection after short-course antiviral therapy
    Liu, Ruyu
    Yang, Liu
    Jiang, Tingting
    Lu, Yao
    Zhang, Lu
    Shen, Ge
    Wu, Shuling
    Chang, Min
    Hao, Hongxiao
    Hu, Leiping
    Gao, Yuanjiao
    Xu, Mengjiao
    Chen, Xiaoxue
    Yi, Wei
    Li, Minghui
    Xie, Yao
    VIRULENCE, 2023, 14 (01)
  • [34] Increased CCR7loPD-1hiCXCR5+CD4+ T Cells in Peripheral Blood Mononuclear Cells Are Correlated with Immune Activation in Patients with Chronic HBV Infection
    Huang, Ya-Xin
    Zhao, Qi-Yi
    Wu, Li-Li
    Xie, Dong-Ying
    Gao, Zhi-Liang
    Deng, Hong
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 2018
  • [35] THE ONCOLYTIC VIRUS PELAREOREP IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITOR ACTIVATES T-CELL FUNCTIONING IN EARLY BREAST CANCER PATIENTS - IMMUNOPHENOTYPE RESULTS FROM AWARE-1 STUDY
    Heineman, Thomas C.
    Loghmani, Houra
    Trauger, Richard
    Salvador, Fernando
    Manso, Luis
    Pascual, Tomas
    Juan, Manel
    Prat, Aleix
    Gavila, Joaquin
    Coffey, Matt
    Azucena Gonzalez-Navarro, E.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A573 - A573
  • [36] Virological response to daclatasvir and asunaprevir combination therapy for chronic hepatitis C virus genotype 1b infection in dialysis patients: A prospective, multicenter study
    Uojima H.
    Kobayashi S.
    Hidaka H.
    Matsumoto S.
    Ohtake T.
    Kinbara T.
    Oka M.
    Yamanouchi Y.
    Kunieda T.
    Yamanoue H.
    Kanemaru T.
    Tsutsumi K.
    Fujikawa T.
    Sung J.H.
    Kako M.
    Renal Replacement Therapy, 3 (1)
  • [37] Monocyte-derived Galectin-9 and PD-L1 differentially impair adaptive and innate immune response in chronic HBV infection and their expression remain unaltered after antiviral therapy
    Dey, Debangana
    Biswas, Satabdi
    Pal, Sourina
    Nandi, Sarthak
    Khatun, Najma
    Jha, Rambha
    Chakraborty, Bidhan Chandra
    Baidya, Ayana
    Ghosh, Ranajoy
    Banerjee, Soma
    Ahammed, S. K. Mahiuddin
    Chowdhury, Abhijit
    Datta, Simanti
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [38] Secreted Phosphoprotein 1 Promoter Genetic Variants Are Associated with the Response to Pegylated Interferon α Plus Ribavirin Combination Therapy in Egyptian Patients with Chronic Hepatitis C Virus Infection
    Ali, Fahmy T.
    Ali, Mohamed A. M.
    Elgizawy, Mayada M. A.
    Elsawy, Ahmed M.
    GUT AND LIVER, 2015, 9 (04) : 516 - 524
  • [39] Initiation of antiretroviral therapy during chronic SIV infection leads to rapid reduction in viral loads and the level of T-cell immune response (vol 35, pg 202, 2006)
    Boyer, J. D.
    Kumar, S.
    Robinson, T.
    Parkinson, R.
    Wu, L.
    Lewis, M.
    Watkins, D., I
    Weiner, D. B.
    JOURNAL OF MEDICAL PRIMATOLOGY, 2007, 36 (01) : 55 - 55
  • [40] CpG oligodeoxynucleotide-adjuvanted fusion peptide derived from HBcAg epitope and HIV-Tat may elicit favorable immune response in PBMCs from patients with chronic HBV infection in the immunotolerant phase
    Wang, Suna
    Han, Qunying
    Zhang, Guoyu
    Zhang, Ni
    Li, Zhu
    Chen, Jinghong
    Lv, Yi
    Li, Na
    Xing, Fanfan
    Tian, Ningqiang
    Zhu, Qianqian
    Liu, Zhengwen
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2011, 11 (04) : 406 - 411
12345